Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

An Electronic Health Intervention for Latina Women Undergoing Breast Cancer Treatment (My Guide for Breast Cancer Treatment): Protocol for a Randomized Controlled Trial.

Yanez B, Baik SH, Oswald LB, Buitrago D, Buscemi J, Iacobelli F, Perez-Tamayo A, Fajardo P, Serrano G, Guitelman J, Penedo FJ.

JMIR Res Protoc. 2019 Dec 13;8(12):e14339. doi: 10.2196/14339.

PMID:
31833834
2.

Identification of Circular RNAs using RNA Sequencing.

Sekar S, Geiger P, Cuyugan L, Boyle A, Serrano G, Beach TG, Liang WS.

J Vis Exp. 2019 Nov 14;(153). doi: 10.3791/59981.

PMID:
31789321
3.

Diagnostic value of blood variables following attenuation of congenital extrahepatic portosystemic shunt in dogs.

Vallarino N, Pil S, Devriendt N, Or M, Vandermeulen E, Serrano G, Paepe D, Bosmans T, de Rooster H.

Vet Rec. 2019 Oct 29. pii: vetrec-2018-105296. doi: 10.1136/vr.105296. [Epub ahead of print]

PMID:
31662576
4.

Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's disease.

Adler CH, Serrano GE, Zhang N, Hinni ML, Lott DG, Mehta SH, Sue LI, Intorcia A, Beach TG.

Parkinsonism Relat Disord. 2019 Nov;68:69-72. doi: 10.1016/j.parkreldis.2019.10.006. Epub 2019 Oct 7.

PMID:
31621624
5.

DeepMSPeptide: peptide detectability prediction using deep learning.

Serrano G, Guruceaga E, Segura V.

Bioinformatics. 2019 Sep 14. pii: btz708. doi: 10.1093/bioinformatics/btz708. [Epub ahead of print]

PMID:
31529040
6.

Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging.

Adler CH, Beach TG, Zhang N, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Sabbagh MN, Serrano GE, Sue LI, Belden CM, Powell J, Jacobson SA, Zamrini E, Shprecher D, Davis KJ, Dugger BN, Hentz JG.

J Neuropathol Exp Neurol. 2019 Oct 1;78(10):891-899. doi: 10.1093/jnen/nlz080.

PMID:
31504679
7.

Treatment of congenital extrahepatic portosystemic shunts in dogs: A systematic review and meta-analysis.

Serrano G, Charalambous M, Devriendt N, de Rooster H, Mortier F, Paepe D.

J Vet Intern Med. 2019 Sep;33(5):1865-1879. doi: 10.1111/jvim.15607. Epub 2019 Aug 31. Review.

8.

Identification of Coding and Long Noncoding RNAs Differentially Expressed in Tumors and Preferentially Expressed in Healthy Tissues.

Unfried JP, Serrano G, Suárez B, Sangro P, Ferretti V, Prior C, Boix L, Bruix J, Sangro B, Segura V, Fortes P.

Cancer Res. 2019 Oct 15;79(20):5167-5180. doi: 10.1158/0008-5472.CAN-19-0400. Epub 2019 Aug 6.

PMID:
31387921
9.

Brain Lewy-Type Synucleinopathy Density Is Associated with a Lower Prevalence of Atherosclerotic Cardiovascular Disease Risk Factors in Patients with Parkinson's Disease1.

Driver-Dunckley ED, Zhang N, Adler CH, Serrano GE, Sue LI, Shill HA, Mehta SH, Belden CM, Zamrini EY, Davis K, Beach TG.

J Parkinsons Dis. 2019;9(3):543-552. doi: 10.3233/JPD-191610.

PMID:
31282425
10.

Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories.

Van den Wijngaert S, Bossuyt N, Ferns B, Busson L, Serrano G, Wautier M, Thomas I, Byott M, Dupont Y, Nastouli E, Hallin M, Kozlakidis Z, Vandenberg O.

Front Public Health. 2019 Jun 18;7:150. doi: 10.3389/fpubh.2019.00150. eCollection 2019.

11.

Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.

Malek-Ahmadi M, Beach TG, Zamrini E, Adler CH, Sabbagh MN, Shill HA, Jacobson SA, Belden CM, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Caviness JN, Driver-Dunckley E, Mehta SH, Shprecher DR, Spann BM, Tariot P, Davis KJ, Long KE, Nicholson LR, Intorcia A, Glass MJ, Walker JE, Callan M, Curry J, Cutler B, Oliver J, Arce R, Walker DG, Lue LF, Serrano GE, Sue LI, Chen K, Reiman EM.

PLoS One. 2019 Jun 25;14(6):e0217566. doi: 10.1371/journal.pone.0217566. eCollection 2019.

12.

Association of AEBP1 and NRN1 RNA expression with Alzheimer's disease and neurofibrillary tangle density in middle temporal gyrus.

Piras IS, Krate J, Delvaux E, Nolz J, De Both MD, Mastroeni DF, Serrano GE, Sue LI, Beach TG, Coleman PD, Huentelman MJ.

Brain Res. 2019 Sep 15;1719:217-224. doi: 10.1016/j.brainres.2019.06.004. Epub 2019 Jun 6.

PMID:
31176712
13.

Regional neuropathology distribution and verbal fluency impairments in Parkinson's disease.

El-Nazer R, Adler CH, Beach TG, Belden CM, Artz J, Shill HA, Driver-Dunckley E, Mehta SH, Sabbagh MN, Serrano GE, Sue LI, Zamrini E, Benge JF.

Parkinsonism Relat Disord. 2019 Aug;65:73-78. doi: 10.1016/j.parkreldis.2019.05.014. Epub 2019 May 10.

PMID:
31109728
14.

Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age.

Wingo AP, Dammer EB, Breen MS, Logsdon BA, Duong DM, Troncosco JC, Thambisetty M, Beach TG, Serrano GE, Reiman EM, Caselli RJ, Lah JJ, Seyfried NT, Levey AI, Wingo TS.

Nat Commun. 2019 Apr 8;10(1):1619. doi: 10.1038/s41467-019-09613-z.

15.

Heritability and genetic variance of dementia with Lewy bodies.

Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T, Neto JL, Carmona S, Dehghani N, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A; International Parkinson's Disease Genomics Consortium, Stone DJ, Bras J.

Neurobiol Dis. 2019 Jul;127:492-501. doi: 10.1016/j.nbd.2019.04.004. Epub 2019 Apr 3.

PMID:
30953760
16.

Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways.

Christensen KR, Beach TG, Serrano GE, Kanaan NM.

Acta Neuropathol Commun. 2019 Feb 28;7(1):29. doi: 10.1186/s40478-019-0675-9.

17.

Assessment of APOE in atypical parkinsonism syndromes.

Sabir MS, Blauwendraat C, Ahmed S, Serrano GE, Beach TG, Perkins M, Rice AC, Masliah E, Morris CM, Pihlstrom L, Pantelyat A, Resnick SM, Cookson MR, Hernandez DG, Albert M, Dawson TM, Rosenthal LS, Houlden H, Pletnikova O, Troncoso J, Scholz SW.

Neurobiol Dis. 2019 Jul;127:142-146. doi: 10.1016/j.nbd.2019.02.016. Epub 2019 Feb 21.

PMID:
30798004
18.

Tau immunoreactivity in peripheral tissues of human aging and select tauopathies.

Dugger BN, Hoffman BR, Scroggins A, Serrano GE, Adler CH, Shill HA, Belden CM, Sabbagh MN, Caviness JN, Driver Dunckley E, Beach TG.

Neurosci Lett. 2019 Mar 23;696:132-139. doi: 10.1016/j.neulet.2018.12.031. Epub 2018 Dec 21.

PMID:
30579993
19.

Tunable Spin-Superconductor Coupling of Spin 1/2 Vanadyl Phthalocyanine Molecules.

Malavolti L, Briganti M, Hänze M, Serrano G, Cimatti I, McMurtrie G, Otero E, Ohresser P, Totti F, Mannini M, Sessoli R, Loth S.

Nano Lett. 2018 Dec 12;18(12):7955-7961. doi: 10.1021/acs.nanolett.8b03921. Epub 2018 Nov 26.

PMID:
30452271
20.

A comprehensive screening of copy number variability in dementia with Lewy bodies.

Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Guerreiro R, Bras J.

Neurobiol Aging. 2019 Mar;75:223.e1-223.e10. doi: 10.1016/j.neurobiolaging.2018.10.019. Epub 2018 Oct 24.

21.

Is There Any Correlation Between Short-Term MRI And Mid-Term Clinical Resultsin Patients Undergoing An Osteochondral Autograft In The Knee?

Figueroa D, Figueroa F, Calvo R, Zilleruelo N, Serrano G, Arellano S.

Acta Orthop Belg. 2017 Dec;83(4):650-658.

PMID:
30423674
22.

Ultralow-temperature device dedicated to soft X-ray magnetic circular dichroism experiments.

Kappler JP, Otero E, Li W, Joly L, Schmerber G, Muller B, Scheurer F, Leduc F, Gobaut B, Poggini L, Serrano G, Choueikani F, Lhotel E, Cornia A, Sessoli R, Mannini M, Arrio MA, Sainctavit P, Ohresser P.

J Synchrotron Radiat. 2018 Nov 1;25(Pt 6):1727-1735. doi: 10.1107/S1600577518012717. Epub 2018 Oct 19.

23.

Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?

Gupta HV, Mehta SH, Zhang N, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Belden CM, Dugger BN, Beach TG, Serrano GE, Sue LI, Davis K, Adler CH.

Mov Disord Clin Pract. 2018 Feb 22;5(2):165-170. doi: 10.1002/mdc3.12589. eCollection 2018 Mar-Apr.

24.

Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4).

Chahine LM, Beach TG, Seedorff N, Caspell-Garcia C, Coffey CS, Brumm M, Adler CH, Serrano GE, Linder C, Mosovsky S, Foroud T, Riss H, Ecklund D, Seibyl J, Jennings D, Arnedo V, Riley L, Dave KD, Mollenhauer B; Systemic sSynuclein Sampling study.

J Parkinsons Dis. 2018;8(4):517-527. doi: 10.3233/JPD-181434.

25.

Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study.

Savica R, Beach TG, Hentz JG, Sabbagh MN, Serrano GE, Sue LI, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Jacobson SA, Belden CM, Davis KJ, Zamrini E, Shprecher DR, Adler CH.

Acta Neurol Scand. 2019 Jan;139(1):76-81. doi: 10.1111/ane.13028. Epub 2018 Oct 7.

26.

Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease.

Ortuño-Lizarán I, Esquiva G, Beach TG, Serrano GE, Adler CH, Lax P, Cuenca N.

Acta Neuropathol Commun. 2018 Sep 10;6(1):90. doi: 10.1186/s40478-018-0596-z.

27.

Impaired hepatic amyloid-beta degradation in Alzheimer's disease.

Maarouf CL, Walker JE, Sue LI, Dugger BN, Beach TG, Serrano GE.

PLoS One. 2018 Sep 7;13(9):e0203659. doi: 10.1371/journal.pone.0203659. eCollection 2018.

28.

The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target.

Petyuk VA, Chang R, Ramirez-Restrepo M, Beckmann ND, Henrion MYR, Piehowski PD, Zhu K, Wang S, Clarke J, Huentelman MJ, Xie F, Andreev V, Engel A, Guettoche T, Navarro L, De Jager P, Schneider JA, Morris CM, McKeith IG, Perry RH, Lovestone S, Woltjer RL, Beach TG, Sue LI, Serrano GE, Lieberman AP, Albin RL, Ferrer I, Mash DC, Hulette CM, Ervin JF, Reiman EM, Hardy JA, Bennett DA, Schadt E, Smith RD, Myers AJ.

Brain. 2018 Sep 1;141(9):2721-2739. doi: 10.1093/brain/awy215.

29.

Multiorgan structures detection using deep convolutional neural networks.

Onieva JO, Serrano GG, Young TP, Washko GR, Carbayo MJL, Estépar RSJ.

Proc SPIE Int Soc Opt Eng. 2018 Feb;10574. pii: 1057428. doi: 10.1117/12.2293761. Epub 2018 Mar 2.

30.

Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4).

Beach TG, Serrano GE, Kremer T, Canamero M, Dziadek S, Sade H, Derkinderen P, Corbillé AG, Letournel F, Munoz DG, White CL 3rd, Schneider J, Crary JF, Sue LI, Adler CH, Glass MJ, Intorcia AJ, Walker JE, Foroud T, Coffey CS, Ecklund D, Riss H, Goßmann J, König F, Kopil CM, Arnedo V, Riley L, Linder C, Dave KD, Jennings D, Seibyl J, Mollenhauer B, Chahine L; Systemic Synuclein Sampling Study (S4).

J Neuropathol Exp Neurol. 2018 Sep 1;77(9):793-802. doi: 10.1093/jnen/nly056.

31.

Validation of a commercial 1,2-o-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester lipase assay for diagnosis of canine pancreatitis.

Goodband EL, Serrano G, Constantino-Casas F, Archer J, Watson PJ, Williams TL.

Vet Rec Open. 2018 May 26;5(1):e000270. doi: 10.1136/vetreco-2017-000270. eCollection 2018.

32.

Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis.

Shprecher DR, Adler CH, Zhang N, Hentz JG, Serrano GE, Dugger BN, Shill HA, Savica R, Caviness JN, Sabbagh MN, Belden CM, Driver-Dunckley E, Mehta SH, Sue LI, Davis KJ, Zamrini E, Beach TG.

Parkinsonism Relat Disord. 2018 Oct;55:92-96. doi: 10.1016/j.parkreldis.2018.05.020. Epub 2018 May 17.

PMID:
29779682
33.

Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementia.

Migrino RQ, Truran S, Karamanova N, Serrano GE, Madrigal C, Davies HA, Madine J, Reaven P, Beach TG.

Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H284-H290. doi: 10.1152/ajpheart.00206.2018. Epub 2018 May 18.

34.

Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Ortuño-Lizarán I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N.

Mov Disord. 2018 Aug;33(8):1315-1324. doi: 10.1002/mds.27392. Epub 2018 May 8.

35.

Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer's Disease.

Yin J, Han P, Song M, Nielsen M, Beach TG, Serrano GE, Liang WS, Caselli RJ, Shi J.

Mol Neurobiol. 2018 Nov;55(11):8592-8601. doi: 10.1007/s12035-018-0977-0. Epub 2018 Mar 24.

36.

Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease.

Pal G, Ouyang B, Verhagen L, Serrano G, Shill HA, Adler CH, Beach TG, Kordower JH; AZSAND.

Mov Disord. 2018 Apr;33(4):652-654. doi: 10.1002/mds.27280. Epub 2018 Jan 30. No abstract available.

37.

Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.

Beach TG, Maarouf CL, Intorcia A, Sue LI, Serrano GE, Lu M, Joshi A, Pontecorvo MJ, Roher AE.

J Alzheimers Dis. 2018;61(4):1509-1516. doi: 10.3233/JAD-170762.

PMID:
29376867
38.

Magnetic bistability of a TbPc2 submonolayer on a graphene/SiC(0001) conductive electrode.

Serrano G, Velez-Fort E, Cimatti I, Cortigiani B, Malavolti L, Betto D, Ouerghi A, Brookes NB, Mannini M, Sessoli R.

Nanoscale. 2018 Feb 8;10(6):2715-2720. doi: 10.1039/c7nr08372f.

PMID:
29372744
39.

Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.

Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J.

Lancet Neurol. 2018 Jan;17(1):64-74. doi: 10.1016/S1474-4422(17)30400-3. Epub 2017 Dec 16.

40.

Laser-captured microglia in the Alzheimer's and Parkinson's brain reveal unique regional expression profiles and suggest a potential role for hepatitis B in the Alzheimer's brain.

Mastroeni D, Nolz J, Sekar S, Delvaux E, Serrano G, Cuyugan L, Liang WS, Beach TG, Rogers J, Coleman PD.

Neurobiol Aging. 2018 Mar;63:12-21. doi: 10.1016/j.neurobiolaging.2017.10.019. Epub 2017 Nov 1.

41.

A primacy code for odor identity.

Wilson CD, Serrano GO, Koulakov AA, Rinberg D.

Nat Commun. 2017 Nov 14;8(1):1477. doi: 10.1038/s41467-017-01432-4.

42.

Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype.

Gerkin RC, Adler CH, Hentz JG, Shill HA, Driver-Dunckley E, Mehta SH, Sabbagh MN, Caviness JN, Dugger BN, Serrano G, Belden C, Smith BH, Sue L, Davis KJ, Zamrini E, Beach TG.

Ann Clin Transl Neurol. 2017 Sep 8;4(10):714-721. doi: 10.1002/acn3.447. eCollection 2017 Oct.

43.

Amyloidogenic medin induces endothelial dysfunction and vascular inflammation through the receptor for advanced glycation endproducts.

Migrino RQ, Davies HA, Truran S, Karamanova N, Franco DA, Beach TG, Serrano GE, Truong D, Nikkhah M, Madine J.

Cardiovasc Res. 2017 Sep 1;113(11):1389-1402. doi: 10.1093/cvr/cvx135.

44.

Radio frequency surface plasma oscillations: electrical excitation and detection by Ar/Ag(111).

Serrano G, Tebi S, Wiespointner-Baumgarthuber S, Müllegger S, Koch R.

Sci Rep. 2017 Aug 29;7(1):9708. doi: 10.1038/s41598-017-10170-y.

45.

GBA mutations in Parkinson disease: earlier death but similar neuropathological features.

Adler CH, Beach TG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Patel A, Sue LI, Serrano G, Jacobson SA, Davis K, Belden CM, Dugger BN, Paciga SA, Winslow AR, Hirst WD, Hentz JG.

Eur J Neurol. 2017 Nov;24(11):1363-1368. doi: 10.1111/ene.13395. Epub 2017 Aug 17.

46.

APP/Aβ structural diversity and Alzheimer's disease pathogenesis.

Roher AE, Kokjohn TA, Clarke SG, Sierks MR, Maarouf CL, Serrano GE, Sabbagh MS, Beach TG.

Neurochem Int. 2017 Nov;110:1-13. doi: 10.1016/j.neuint.2017.08.007. Epub 2017 Aug 12. Review.

47.

Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson's Disease.

Dashtipour K, Tafreshi A, Adler C, Beach T, Chen X, Serrano G, Tashiro S, Wang C.

Brain Sci. 2017 Jun 27;7(7). pii: E74. doi: 10.3390/brainsci7070074.

48.

Peripheral synucleinopathy in early Parkinson's disease: Submandibular gland needle biopsy findings.

Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG.

Mov Disord. 2017 May;32(5):722-723. doi: 10.1002/mds.27044. No abstract available.

PMID:
28513078
49.

Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation.

Hosokawa M, Kondo H, Serrano GE, Beach TG, Robinson AC, Mann DM, Akiyama H, Hasegawa M, Arai T.

Sci Rep. 2017 May 4;7(1):1513. doi: 10.1038/s41598-017-01587-6.

50.

Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.

Walker DG, Lue LF, Tang TM, Adler CH, Caviness JN, Sabbagh MN, Serrano GE, Sue LI, Beach TG.

Neurobiol Aging. 2017 Jun;54:175-186. doi: 10.1016/j.neurobiolaging.2017.03.007. Epub 2017 Mar 16.

Supplemental Content

Loading ...
Support Center